BPC-157
Experimental peptide studied predominantly in preclinical models involving tissue repair and other biological processes.
Very limited human evidenceExplore this ingredient →← All stacks & combinationsINGREDIENT INGREDIENT POPULAR GOALS THE COMMUNITY RATIONALE THE OPEN QUESTION BPC-157 GHK-CU Research review · individual ingredient Regulatory guidance · ingredient safety
Community combination
BPC-157 + GHK-Cu
BPC-157 + GHK-Cu brings skin renewal and broader tissue-repair research into one conversation. The evidence still comes from studying the ingredients separately.
Recovery & HealingSkin & Hair
01
THE BUILDING BLOCKS
What’s in it?
GHK-Cu
Copper-binding peptide studied in skin, wound and cellular research.
Limited evidenceExplore this ingredient →The ingredients listed here do not specify a particular product or mixing ratio. Pre-mixed products may differ from the formulations used in research.
02
PEOPLE & EXPERIENCE
Why this combination is discussed
BPC-157 + GHK-Cu brings skin renewal and broader tissue-repair research into one conversation. The evidence still comes from studying the ingredients separately.
Recovery & HealingSkin & Hair
Interest in this pairing centres on tissue repair and the way skin renews and rebuilds itself.
Research on the ingredients covers skin, wound healing and tissue repair. Findings depend on the formulation and how it is used.
Community experience can explain why a pairing has become popular. It cannot show whether the ingredients work better together or whether a mixed product is stable, accurately dosed or safe.
03
THE REASON FOR INTEREST
Why people combine them
Interest in this pairing centres on tissue repair and the way skin renews and rebuilds itself.
How their research overlaps
Research on the ingredients covers skin, wound healing and tissue repair. Findings depend on the formulation and how it is used.
The individual profiles explain each ingredient’s potential benefits and research. Even when their effects seem complementary, studies are needed to find out whether using them together adds a benefit.
04
No human combination study found in this searchWHAT THE RESEARCH CAN SUPPORT
Evidence for this combination
We did not find a human study testing these ingredients together in our targeted search. That leaves their combined benefits and safety uncertain; it does not show that the pairing is ineffective.
The BPC-157 review provides background on that ingredient, rather than this pairing. Research on individual ingredients or products applied to the skin does not establish the effects of the combination.
Explore the sources below ↓05
RESEARCH & COMMUNITY CONTEXT
Doses & duration
Start with each ingredient—not an invented combined dose
No validated combined starting dose exists. The cards below preserve the practical structure people look for while keeping each ingredient’s reported pattern separate.
Anecdotal / unvalidated
- Starting point discussed
- Online communities discuss many different starting amounts and routes; there is no accepted clinical starting dose.
- Duration / cycle
- Short 'cycles' are commonly discussed, often framed around injury recovery rather than chronic treatment.
- Continuation / break
- Maintenance use is discussed online, but no clinically validated maintenance schedule has been identified.
Anecdotal injectable pattern · topical products vary
- Starting point discussed
- Topical use is usually discussed by product strength and directions. Injectable discussions often begin around 1 mg per day, but no human dose-finding study validates that starting amount.
- Duration / cycle
- Four-to-eight-week topical or injected courses are commonly described. Formulation, route and absorbed exposure are not interchangeable.
- Continuation / break
- Intermittent topical use is widely discussed; there is no validated injectable maintenance dose, cycle or break interval.
Using two ingredients in the same period and mixing them in one vial or syringe are different questions. Separate schedules cannot establish compatibility, interactions or a safe combined total.
06
WHAT REMAINS UNCERTAIN
Safety & uncertainties
- The combination needs its own safety research, including possible interactions and side effects.
- What a product contains, how it is made and how it is used all matter. Products sold under the same name may differ.
- A clinician can assess how existing medicines or health conditions affect the risks. These pages provide general information, not personal treatment advice.
07
FOLLOW THE EVIDENCE
Sources & search record
Last source check: 14 September 2026
Each link explains what it covers: the combination itself, an individual ingredient or safety information. A trial record and a paper can describe the same study.
Emerging Use of BPC-157 in Orthopaedic Sports Medicine (2025) ↗
A review of BPC-157 research, mostly from lab and animal studies. It brings existing findings together rather than testing a stack.
FDA: peptide compounding safety concerns ↗
Safety information about individual ingredients, rather than the combination. This is US guidance, not a statement of UK legal status.
About this search
We used targeted web searches for ingredient pairs, including searches focused on PubMed and ClinicalTrials.gov. We followed relevant papers, research reviews and FDA safety information, checking whether the ingredients were actually given together and how they were used. Some full papers were unavailable, so we relied on their published summaries. Web searches can miss studies: this was a targeted source check, not an exhaustive or systematic review, a clinical assessment or a review of UK regulation. The links below let you explore further; search results are not evidence on their own.
Search terms used
- "BPC-157" "GHK-Cu" study trial
- "BPC-157" "GHK-Cu" site:pubmed.ncbi.nlm.nih.gov
- site:clinicaltrials.gov "BPC-157" ("TB-500" OR "thymosin beta" OR "GHK-Cu" OR "KPV")
Search for these ingredients together:
Studies may use different names for the same ingredient. The search terms above show which alternatives we checked. Community experiences can explain interest in a stack, but we did not count anecdotes or seller claims as clinical studies.